Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mianhuahua Flavonoids Tablets in healthy adults
NCT02622230Phase 1Unknown
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Start
- Dec 2015
- Primary completion
- Oct 2016
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) (2 arms), sponsored by Xinjiang Uygur Pharmaceutical Co., Ltd. Primary endpoint: Frequency of drug-related clinical adverse events up to 36 Days. Status: unknown.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02622230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622230.